Search

Author/Creator Miller, Wilson H.

1. Health-related quality of life in patients treated with pembrolizumab for microsatellite instability–high/mismatch repair–deficient advanced solid tumours: Results from the KEYNOTE-158 study. (July 2022)

Authors:
Maio, Michele; Amonkar, Mayur M.; Norquist, Josephine M.; Ascierto, Paolo A.; Manzyuk, Ludmila; Motola-Kuba, Daniel; Penel, Nicolas; Cassier, Philippe A.; Bariani, Giovanni M.; De Jesus Acosta, Ana; Doi, Toshihiko; Longo, Federico; Miller, Wilson H.; Oh, Do-Youn; Gottfried, Maya; Wang, Ruixue; No...
Journal:
European journal of cancer
Issue:
Volume 169(2022)
Page Start:
188
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. High mortality among hospital-acquired COVID-19 infection in patients with cancer: A multicentre observational cohort study. (November 2020)

Authors:
Elkrief, Arielle; Desilets, Antoine; Papneja, Neha; Cvetkovic, Lena; Groleau, Catherine; Lakehal, Yahia Abdelali; Shbat, Layla; Richard, Corentin; Malo, Julie; Belkaid, Wiam; Cook, Erin; Doucet, Stéphane; Tran, Thai Hoa; Jao, Kevin; Daaboul, Nathalie; Bhang, Eric; Loree, Jonathan M.; Miller, Wils...
Journal:
European journal of cancer
Issue:
Volume 139(2020)
Page Start:
181
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Increased protein processing gene signature in HDACi-resistant cells predicts response to proteasome inhibitors. Issue 1 (2nd January 2017)

Authors:
Dupéré-Richer, Daphné; Kinal, Mena; Pettersson, Filippa; Emond, Audrey; Calvo-Vidal, M. Nieves; Nichol, Jessica N.; Guilbert, Cynthia; Plourde, Dany; Klein Oros, Kathleen; Nielsen, Torsten H.; Ezponda, Teresa; Licht, Jonathan D.; Johnson, Nathalie A.; Assouline, Sarit; Cerchietti, Leandro; Miller...
Journal:
Leukemia & lymphoma
Issue:
Volume 58:Issue 1(2017)
Page Start:
218
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. KEYNOTE-022: Pembrolizumab with trametinib in patients with BRAF wild-type melanoma or advanced solid tumours irrespective of BRAF mutation. (January 2022)

Authors:
Maio, Michele; Carlino, Matteo S.; Joshua, Anthony M.; McWhirter, Elaine; Ribas, Antoni; Ascierto, Paolo A.; Miller, Wilson H.; Butler, Marcus O.; Ferrucci, Pier Francesco; Zielinski, Robert R.; Del Vecchio, Michele; Gasal, Eduard; Ghori, Razi; Diede, Scott J.; Croydon, Elizabeth; Hamid, Omid
Journal:
European journal of cancer
Issue:
Volume 160(2022)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAFV600 mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis. (July 2017)

Authors:
Blank, Christian U.; Larkin, James; Arance, Ana M.; Hauschild, Axel; Queirolo, Paola; Del Vecchio, Michele; Ascierto, Paolo A.; Krajsova, Ivana; Schachter, Jacob; Neyns, Bart; Garbe, Claus; Chiarion Sileni, Vanna; Mandalà, Mario; Gogas, Helen; Espinosa, Enrique; Hospers, Geke A.P.; Miller, Wilson...
Journal:
European journal of cancer
Issue:
Volume 79(2017)
Page Start:
176
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma. (November 2017)

Authors:
Petrella, Teresa M.; Robert, Caroline; Richtig, Erika; Miller, Wilson H.; Masucci, Giuseppe V.; Walpole, Euan; Lebbe, Celeste; Steven, Neil; Middleton, Mark R.; Hille, Darcy; Zhou, Wei; Ibrahim, Nageatte; Cebon, Jonathan
Journal:
European journal of cancer
Issue:
Volume 86(2017)
Page Start:
115
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Pembrolizumab in Patients With Microsatellite Instability–High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study. Issue 7 (1st March 2022)

Authors:
O'Malley, David M.; Bariani, Giovanni Mendonca; Cassier, Philippe A.; Marabelle, Aurelien; Hansen, Aaron R.; De Jesus Acosta, Ana; Miller, Wilson H.; Safra, Tamar; Italiano, Antoine; Mileshkin, Linda; Xu, Lei; Jin, Fan; Norwood, Kevin; Maio, Michele
Journal:
Journal of clinical oncology
Issue:
Volume 40:Issue 7(2022)
Page Start:
752
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma. Issue 1 (21st November 2017)

Authors:
Jamal, Rahima; Lapointe, Réjean; Cocolakis, Eftihia; Thébault, Paméla; Kazemi, Shirin; Friedmann, Jennifer E.; Dionne, Jeanne; Cailhier, Jean-François; Bélanger, Karl; Ayoub, Jean-Pierre; Le, Huy; Lambert, Caroline; El-Hajjar, Jida; van Kempen, Léon C.; Spatz, Alan; Miller, Wilson H.
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4:Issue 1(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Silencing PEX26 as an unconventional mode to kill drug-resistant cancer cells and forestall drug resistance. Issue 3 (4th March 2022)

Authors:
Dahabieh, Michael S.; Huang, Fan; Goncalves, Christophe; Flores González, Raúl Ernesto; Prabhu, Sathyen; Bolt, Alicia; Di Pietro, Erminia; Khoury, Elie; Heath, John; Xu, Zi Yi; Rémy-Sarrazin, Joelle; Mann, Koren K.; Orthwein, Alexandre; Boisvert, François-Michel; Braverman, Nancy; Miller, Wilson ...
Journal:
Autophagy
Issue:
Volume 18:Issue 3(2022)
Page Start:
540
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗